Antibodies
15 April 2013
Springtime for antibody-drug conjugates11 April 2013
Emergent BioSolutions Presents Efficacy Data on ES210; a Bispecific ADAPTIR Molecule for Treating Autoimmune Diseases10 April 2013
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential Therapeutics for Solid and Liquid Tumors9 April 2013
Celldex Presents CDX-1127 In Vitro Human Data Consistent With Strong Potency and Safety Profile at AACR 20138 April 2013
Spirogen and BioAtla Present Positive Data on Next-Generation Warheads in ADCS against Cancer4 April 2013
GlaxoSmithKline announces start of phase III study of Benlysta® (belimumab ) in patients with vasculitis4 April 2013
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of Daclizumab HYP in Multiple Sclerosis26 March 2013
Cangene announces FDA approval of Botulism AntitoxinNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports